Stocktoria
Indaptus Therapeutics, Inc. INDP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-09-07
Chart by TradingView
1/9
Piotroski F — financial health
-40.02
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$19.8M | -$15.4M | -$16.4M | -$14.9M | -$7.7M |
| Net income | -$20.8M | -$15.0M | -$15.4M | -$14.3M | -$7.7M |
| Operating cash flow | -$14.8M | -$12.3M | -$13.4M | -$13.1M | -$11.3M |
| Free cash flow | — | — | — | — | -$11.3M |
| Total assets | $9.3M | $7.3M | $14.9M | $28.1M | $40.6M |
| Total liabilities | — | $3.4M | $2.8M | $3.4M | $4.7M |
| Shareholders' equity | $3.2M | $3.9M | $12.1M | $24.6M | $35.9M |
| Ratios | |||||
| Return on assets | -223.9% | -204.7% | -103.3% | -51.0% | -19.0% |
| Return on equity | -661.5% | -380.8% | -127.7% | -58.2% | -21.5% |
| Current ratio | 1.51 | 1.95 | 5.05 | 7.94 | 8.77 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -40.02 (distress)
- Working capital / assets 0.339
- Retained earnings / assets -8.731
- EBIT / assets -2.13
- Equity / liabilities 0.512
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001857044 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.